KRW 96700.0
(-6.84%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 17.79 Billion KRW | -1.47% |
2022 | 15.83 Billion KRW | 0.18% |
2021 | 15.8 Billion KRW | -52.81% |
2020 | 33.49 Billion KRW | 2.56% |
2019 | 32.65 Billion KRW | 645.0% |
2018 | 4.38 Billion KRW | -16.29% |
2017 | 5.23 Billion KRW | 95.24% |
2016 | 2.68 Billion KRW | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 25.87 Billion KRW | -0.53% |
2024 Q1 | 26.69 Billion KRW | 508.33% |
2023 Q1 | 2.79 Billion KRW | -40.65% |
2023 Q2 | 7.58 Billion KRW | 171.24% |
2023 Q3 | 830.98 Million KRW | -89.04% |
2023 Q4 | 4.38 Billion KRW | 428.12% |
2023 FY | 15.6 Billion KRW | -1.47% |
2022 Q1 | 1.57 Billion KRW | -88.31% |
2022 FY | 15.83 Billion KRW | 0.18% |
2022 Q3 | 2.22 Billion KRW | -69.19% |
2022 Q2 | 7.22 Billion KRW | 360.02% |
2022 Q4 | 4.71 Billion KRW | 111.53% |
2021 FY | 15.8 Billion KRW | -52.81% |
2021 Q3 | 665.82 Million KRW | 0.0% |
2021 Q4 | 13.44 Billion KRW | 1918.99% |
2020 FY | 33.49 Billion KRW | 2.56% |
2019 FY | 32.65 Billion KRW | 645.0% |
2018 FY | 4.38 Billion KRW | -16.29% |
2017 FY | 5.23 Billion KRW | 95.24% |
2016 FY | 2.68 Billion KRW | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
HLB Co., Ltd. | -6.01 Billion KRW | 396.006% |
iNtRON Biotechnology, Inc. | 4.56 Billion KRW | -290.217% |
BINEX Co., Ltd. | 56.65 Billion KRW | 68.587% |
Bioneer Corporation | 199.25 Billion KRW | 91.068% |
Anterogen.Co.,Ltd. | 2.21 Billion KRW | -704.056% |
MEDIPOST Co., Ltd. | 40.18 Billion KRW | 55.711% |
CrystalGenomics, Inc. | 1.45 Billion KRW | -1121.499% |
Helixmith Co., Ltd | 2.12 Billion KRW | -738.763% |
Chabiotech Co.,Ltd. | 255.19 Billion KRW | 93.026% |
Medy-Tox Inc. | 128.16 Billion KRW | 86.113% |
Peptron, Inc. | 1.14 Billion KRW | -1460.374% |
Amicogen, Inc. | 51.51 Billion KRW | 65.451% |
Genexine, Inc. | 387.48 Million KRW | -4493.032% |
HLB Therapeutics Co.,Ltd. | 6.69 Billion KRW | -165.859% |
ALTEOGEN Inc. | 31.19 Billion KRW | 42.955% |
PharmaResearch Co., Ltd. | 182.25 Billion KRW | 90.235% |
SillaJen, Inc. | 1.45 Billion KRW | -1121.719% |
JETEMA, Co., Ltd. | 26.58 Billion KRW | 33.047% |
OliX Pharmaceuticals,Inc | 14.42 Billion KRW | -23.401% |
Genomictree Inc. | -1.03 Billion KRW | 1813.596% |
MedPacto, Inc. | -1.83 Billion KRW | 1071.116% |
D&D Pharmatech | 18.67 Billion KRW | 4.71% |
EASY BIO,Inc. | 50.88 Billion KRW | 65.025% |
GI Innovation, Inc. | 1.98 Billion KRW | -794.596% |